Cited by 195Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology Research

Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss

Open access
Wang, Lei, Chiang, Hsueh-Cheng, Wu, Wenjuan, Liang, Bin, Xie, Zuolei, Yao, Xinsheng, Ma, Weiwei, Du, Shuwen +1 more·2012·Proceedings of the National Academy of Sciences

Abstract

Current understanding of amyloid-β (Aβ) metabolism and toxicity provides an extensive list of potential targets for developing drugs for treating Alzheimer’s disease. We took two independent approaches, including synaptic-plasticity–based analysis and behavioral screening of synthetic compounds, for identifying single compounds that are capable of rescuing the Aβ-induced memory loss in both transgenic fruit fly and transgenic mouse models. Two clinically available drugs and three synthetic compounds not only showed positive effects in behavioral tests but also antagonized the Aβ oligomers-induced activation of the epidermal growth factor receptor (EGFR). Such surprising converging outcomes from two parallel approaches lead us to conclude that EGFR is a preferred target for treating Aβ-induced memory loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1208011109

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, L., Chiang, H.-C., Wu, W., Liang, B., Xie, Z., Yao, X., Ma, W., Du, S., & Zhong, Y.
Affiliations
  • Tsinghua University (CN)
  • Cold Spring Harbor Laboratory (US)
  • Tsinghua Shenzhen International Graduate School (CN)
  • Hainan Normal University (CN)
  • JoeKai Biotech, LLC, Beijing 100084, China; and
  • Division of Life Science and Health, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China;
Venue
Proceedings of the National Academy of Sciences
Published
2012-09-27
Volume
109
Issue
41
Pages
16743-16748
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2091619946
Cited by
190
References
45
Citations by year
2026: 9 · 2025: 16 · 2024: 21 · 2023: 25 · 2022: 14 · 2021: 18 · 2020: 13 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 14 · 2013: 6 · 2012: 2
FWCI
7.07
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
epidermal growth factor receptor, amyloid-beta, Alzheimer's disease, memory loss, amyloid-beta oligomers, synaptic plasticity, behavioral screening, synthetic compounds, drug repurposing, transgenic mouse model
MeSH terms
Erlotinib Hydrochloride, Gefitinib, Animals, Chlorocebus aethiops, Drosophila, Drug Evaluation, Preclinical, Humans, Memantine, Memory, Memory Disorders, Mice, Transgenic, Peptide Fragments, Quinazolines, Blotting, Western, Molecular Structure, Amyloid beta-Peptides, Maze Learning, COS Cells, Drosophila Proteins, Animals, Genetically Modified, Protein Kinase Inhibitors, Mice, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review